251 filings
Page 11 of 13
8-K/A
67221ft8zanfis j6enc
23 Jan 13
Consolidated Statements of Operations
12:00am
8-K
9tfzb
11 Dec 12
Changes in Registrant's Certifying Accountant
12:00am
8-K
upytzikf6x7t38g8ds6
14 Nov 12
Completion of Acquisition or Disposition of Assets
12:00am
8-K
iox200a6meg7
5 Nov 12
Nabi Biopharmaceuticals Announces Special Cash Dividend
12:00am
8-K
gf3qczq4bi8lh51l
26 Oct 12
Other Events
12:00am
8-K
lyk3trgy9gi1n1l
24 Oct 12
Material Modifications to Rights of Security Holders
12:00am
8-K
9rhjdtx0 fmkc
23 Oct 12
Submission of Matters to a Vote of Security Holders
12:00am
8-K
h8v 8mm1yf
19 Oct 12
Nabi Biopharmaceuticals Announces Exchange Ratio for Proposed Business
12:00am
8-K
jmgm391jlyham
17 Oct 12
Results of NicVAX®Phase II Study in Combination with Varenicline
12:00am
8-K
y1jvost 4a
16 Oct 12
Nabi Biopharmaceuticals Sets Record Date for Cash Dividend
12:00am
8-K
3ezcfdvi103d6m 1x
12 Oct 12
Regulation FD Disclosure
12:00am
8-K
pieojg5vnns3
25 Sep 12
Nabi Biopharmaceuticals Announces Adjournment of Special Meeting of
12:00am
8-K
y721z5u
18 Sep 12
Entry into a Material Definitive Agreement
12:00am
8-K
691y18g6 pvvh
9 Aug 12
Nabi Biopharmaceuticals Announces Second Quarter 2012 Financial Results
12:00am
8-K
iwh014o
8 Aug 12
Entry into a Material Definitive Agreement
12:00am
8-K
jw9 u3m3hf7pb08ws
20 Jul 12
Other Events
12:00am
8-K/A
5z5xdi74
12 Jul 12
Departure of Directors or Certain Officers
12:00am
8-K
w0ol5e dxweln4yditj
12 Jul 12
Departure of Directors or Certain Officers
12:00am
8-K
i3v2w9diit0t23c8cg49
14 Jun 12
Departure of Directors or Certain Officers
12:00am
8-K
fbs01wc8awv8ytfmcw1o
10 May 12
Nabi Biopharmaceuticals Announces First Quarter 2012 Financial Results
12:00am